摘要
Tumor cells may escape immune surveillance mainlyby (1) down regulation of major histocompatibilitycomplex (MHC) molecules or alteration of antigen-processing pathways; (2) low-level of cytokines in thevicinity of the tumor, which can’t activate immunosystemeffectively. Recent studies have shown that geneticallyengineered tumor cells expressing cytokines such as IL-2IFN-γ can induce greater CTL activity and activate NK,LAK and TIL. Besides IFN-γ can enhance the
出处
《中国实验血液学杂志》
CAS
CSCD
1997年第3期305-305,共1页
Journal of Experimental Hematology